Literature DB >> 12964773

Evaluation of counterions for electrospray ionization mass spectral analysis of a highly sulfated carbohydrate, sucrose octasulfate.

Nur Sibel Gunay1, Keiko Tadano-Aritomi, Toshihiko Toida, Ineo Ishizuka, Robert J Linhardt.   

Abstract

A systematic approach was used to evaluate the electrospray ionization mass spectral (ESI-MS) analysis of sucrose octasulfate (SOS), an important pharmaceutical agent. SOS represents a model for other suffated carbohydrates, such as heparin and glycosaminoglycan-derived oligosaccharides that also are highly sulfated and pose difficult analytical problems. A survey of ammonium counterions showed that 1 degree, 2 degrees, and 3 degrees ammonium salts of SOS gave substantial fragmentation as a result of sulfate loss. In contrast, quaternary ammonium and phosphonium salts gave excellent ESI spectra, particularly in the positive ion mode. This represents the first report of the ESI-MS analysis of sulfated carbohydrates in the positive ion mode.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12964773     DOI: 10.1021/ac034053l

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  12 in total

1.  Enhanced detection of sulfated glycosylation sites in glycoproteins.

Authors:  Hui Jiang; Janet Irungu; Heather Desaire
Journal:  J Am Soc Mass Spectrom       Date:  2005-01-13       Impact factor: 3.109

2.  Synthesis, separation, and characterization of amphiphilic sulfated oligosaccharides enabled by reversed-phase ion pairing LC and LC-MS methods.

Authors:  Amanda M Fenner; Robert J Kerns
Journal:  Carbohydr Res       Date:  2011-09-24       Impact factor: 2.104

3.  Glycosaminoglycan characterization by electrospray ionization mass spectrometry including fourier transform mass spectrometry.

Authors:  Tatiana N Laremore; Franklin E Leach; Kemal Solakyildirim; I Jonathan Amster; Robert J Linhardt
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

4.  ESI-MS differential fragmentation of positional isomers of sulfated oligosaccharides derived from carrageenans and agarans.

Authors:  Alan G Gonçalves; Diogo R B Ducatti; T Bruce Grindley; M Eugênia R Duarte; Miguel D Noseda
Journal:  J Am Soc Mass Spectrom       Date:  2010-04-07       Impact factor: 3.109

5.  Ionic liquid matrix for direct UV-MALDI-TOF-MS analysis of dermatan sulfate and chondroitin sulfate oligosaccharides.

Authors:  Tatiana N Laremore; Fuming Zhang; Robert J Linhardt
Journal:  Anal Chem       Date:  2007-02-15       Impact factor: 6.986

6.  Competing fragmentation processes in tandem mass spectra of heparin-like glycosaminoglycans.

Authors:  Estee F Naggar; Catherine E Costello; Joseph Zaia
Journal:  J Am Soc Mass Spectrom       Date:  2004-11       Impact factor: 3.109

7.  Matrix-assisted laser desorption/ionization mass spectrometric analysis of uncomplexed highly sulfated oligosaccharides using ionic liquid matrices.

Authors:  Tatiana N Laremore; Saravanababu Murugesan; Tae-Joon Park; Fikri Y Avci; Dmitri V Zagorevski; Robert J Linhardt
Journal:  Anal Chem       Date:  2006-03-15       Impact factor: 6.986

8.  Solid-phase synthesis of alpha-glucosamine sulfoforms with fragmentation analysis by tandem mass spectrometry.

Authors:  Runhui Liu; Chamnongsak Chanthamontri; Hongling Han; Jesús M Hernández-Torres; Karl V Wood; Scott A McLuckey; Alexander Wei
Journal:  J Org Chem       Date:  2008-07-09       Impact factor: 4.354

9.  Matrix-assisted laser desorption/ionization mass spectrometric analysis of polysulfated-derived oligosaccharides using pyrenemethylguanidine.

Authors:  Keiichiro Ohara; Jean-Claude Jacquinet; Diane Jouanneau; William Helbert; Michael Smietana; Jean-Jacques Vasseur
Journal:  J Am Soc Mass Spectrom       Date:  2008-09-06       Impact factor: 3.109

10.  Improved matrix-assisted laser desorption/ionization mass spectrometric detection of glycosaminoglycan disaccharides as cesium salts.

Authors:  Tatiana N Laremore; Robert J Linhardt
Journal:  Rapid Commun Mass Spectrom       Date:  2007       Impact factor: 2.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.